NORA O'BRIEN: Open Payments
NPI 1841613205 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$500 in 26 payments from 12 companies in 2025. Trend: 2023 $288 · 2024 $191 · 2025 $500
Food & beverage: $500
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $82 |
| GlaxoSmithKline, LLC. | 5 | $82 |
| Novo Nordisk Inc | 4 | $73 |
| Novartis Pharmaceuticals Corporation | 2 | $56 |
| ABBVIE INC. | 2 | $47 |
| Amgen Inc. | 2 | $37 |
| Exact Sciences Corporation | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
| Procept Biorobotics Corporation | 1 | $21 |
Products named: Wegovy, LEQVIO, TRELEGY ELLIPTA, NURTEC ODT, UBRELVY, REPATHA, ELIQUIS, SHINGRIX.
Industry payments across MO — which companies pay providers there.
